Senator Mike Lee, the Ranking Member on the Senate Judiciary Committee’s Antitrust Subcommittee, sent a letter to the Federal Trade Commission regarding the proposed merger between Express Scripts (ESRX) and Medco Health Solutions (MHS). Lee noted that the merger of these two large pharmacy benefit managers is a significant transaction that should be given careful consideration by the FTC. Lee said, “The merger of these PBMs may pose some risks to the market’s competitive balance but overall has the potential to create meaningful efficiencies and provide significant savings for consumers...“I am not aware of significant evidence that this merger will result in decreased competition among viable PBMs able to service most companies and accounts.”
European stocks rose for a third straight session on Monday and the euro bounced back from two-year lows, as Greek …
3 comments